SOR-C13

Modify Date: 2024-04-07 18:13:16

SOR-C13 Structure
SOR-C13 structure
Common Name SOR-C13
CAS Number 1187852-48-7 Molecular Weight 1565.81
Density N/A Boiling Point N/A
Molecular Formula C72H116N20O19 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of SOR-C13


SOR-C13, a carboxy-terminal truncated peptide, is a high-affinity TRPV6 antagonist with an IC50 value of 14 nM. TRPV6 is a non-voltage gated calcium channel that is associated with malignancy and poor prognosis in breast cancer. SOR-C13 has anticancer activity[1].

 Names

Name SOR-C13

 SOR-C13 Biological Activity

Description SOR-C13, a carboxy-terminal truncated peptide, is a high-affinity TRPV6 antagonist with an IC50 value of 14 nM. TRPV6 is a non-voltage gated calcium channel that is associated with malignancy and poor prognosis in breast cancer. SOR-C13 has anticancer activity[1].
Related Catalog
In Vivo SOR-C13 (i.p.; 400,600 or 800 mg/kg; daily; on days 1 to 12) can effectively inhibit the growth of tumor in female NOD/SCID mice with SKOV-3 cell[2].
References

[1]. S Fu , et al. Erratum to: First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors. Invest New Drugs. 2017 Jun;35(3):397. 

[2]. Hui Xue, et al. Inhibition of Transient Receptor Potential Vanilloid 6 channel, elevated in human ovarian cancers, reduces tumour growth in a xenograft model. J Cancer. 2018 Aug 6;9(17):3196-3207. 

 Chemical & Physical Properties

Molecular Formula C72H116N20O19
Molecular Weight 1565.81
Top Suppliers:I want be here

Get all suppliers and price by the below link:

SOR-C13 suppliers

SOR-C13 price